A Phase 1b/2 Study of Chidamide Combined with CHOP in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL)

被引：2

作者：

Shi, Yuankai ^{[1
]}

Gui, Lin ^{[1
]}

Cao, Junning ^{[2
]}

Zhang, Huilai ^{[3
]}

Zhu, Jun ^{[4
]}

Ji, Dongmei ^{[5
]}

Fan, Qian ^{[3
]}

Song, Yuqin ^{[4
]}

Shen, Weina ^{[5
]}

Bai, Guiying ^{[3
]}

Han, Ming-Zhe ^{[6
]}

Jiang, Shiyu ^{[1
]}

机构：

[1] Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticancer Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China

[2] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai Med Coll, Shanghai, Peoples R China

[3] Tianjin Med Univ Canc Inst & Hosp, Dept Lymphoma, Sino US Ctr Lymphoma & Leukemia Res, Natl Clin Res Ctr Canc,Key Lab Canc Prevent & The, Tianjin, Peoples R China

[4] Peking Univ Canc Hosp & Inst, Dept Lymphoma, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

[5] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai Med Coll, Shanghai, Peoples R China

[6] Chinese Acad Med Sci, Hematopoiet Stem Cell Transplantat Ctr, Inst Hematol, Tianjin, Peoples R China

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-128078

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2840

引用

页数：3

共 50 条

[1] A Multicenter, Phase III Study of Chidamide, Azacitidine Combined with CHOP Versus CHOP in Patients with Untreated Peripheral T-Cell Lymphoma
Wei, Chong
Zhang, Yan
Li, Jian
Zhang, Wei
Zhou, Daobin
BLOOD, 2022, 140 : 6567 - 6568
[2] The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
Wei Zhang
Liping Su
Lihong Liu
Yuhuan Gao
Quanshun Wang
Hang Su
Yuhuan Song
Huilai Zhang
Jing Shen
Hongmei Jing
Shuye Wang
Xinan Cen
Hui Liu
Aichun Liu
Zengjun Li
Jianmin Luo
Jianxia He
Jingwen Wang
OAOConnor
Daobin Zhou
Cancer Biology & Medicine, 2021, 18 (03) : 841 - 848
[3] The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
Zhang, Wei
Su, Liping
Liu, Lihong
Gao, Yuhuan
Wang, Quanshun
Su, Hang
Song, Yuhuan
Zhang, Huilai
Shen, Jing
Jing, Hongmei
Wang, Shuye
Cen, Xinan
Liu, Hui
Liu, Aichun
Li, Zengjun
Luo, Jianmin
He, Jianxia
Wang, Jingwen
O'Connor, O. A.
Zhou, Daobin
CANCER BIOLOGY & MEDICINE, 2021, 18 (03) : 841 - 848
[4] y Combination of Chidamide with the CHOEP Regimen in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL): A Prospective, Multicenter, Single-Arm, Phase 1b/2 Trial
Zhang, Wei
Su, Liping
Liu, Lihong
Gao, Yuhuan
Wang, Quanshun
Su, Hang
Song, Yuqin
Zhang, Huilai
Shen, Jing
Jing, Hongmei
Wang, Shuye
Cen, Xinan
Liu, Hui
Liu, Aichun
Li, Zengjun
Luo, Jianmin
He, Jianxia
Wang, Jingwen
O'Connor, Owen A.
Zhou, Daobin
BLOOD, 2019, 134
[5] The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
Wei Zhang
Liping Su
Lihong Liu
Yuhuan Gao
Quanshun Wang
Hang Su
Yuhuan Song
Huilai Zhang
Jing Shen
Hongmei Jing
Shuye Wang
Xinan Cen
Hui Liu
Aichun Liu
Zengjun Li
Jianmin Luo
Jianxia He
Jingwen Wang
O.A.O'Connor
Daobin Zhou
Cancer Biology & Medicine , 2021, (03) : 841 - 848
[6] Chidamide combined with cyclophosphamide, doxorubicin,vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma
Lin Gui
Junning Cao
Dongmei Ji
Huilai Zhang
Qian Fan
Jun Zhu
Yuqin Song
Shiyu Jiang
Zhiqiang Ning
Jia Yu
Yuankai Shi
Chinese Journal of Cancer Research, 2021, 33 (05) : 616 - 626
[7] Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma
Gui, Lin
Cao, Junning
Ji, Dongmei
Zhang, Huilai
Fan, Qian
Zhu, Jun
Song, Yuqin
Jiang, Shiyu
Ning, Zhiqiang
Yu, Jia
Shi, Yuankai
CHINESE JOURNAL OF CANCER RESEARCH, 2021, 33 (05) : 616 - 626
[8] Pralatrexate in Combination with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL): A Phase 1 Dose-Escalation Study
Shustov, Andrei
Johnston, Patrick B.
Barta, Stefan Klaus
Bhat, Gajanan
Reddy, Guru
Oki, Yasuhiro
BLOOD, 2017, 130
[9] Multicenter phase II study of romidepsin plus lenalidomide for patients with previously untreated peripheral T-cell lymphoma (PTCL).
Ruan, Jia
Zain, Jasmine M.
Palmer, Brett
Jovanovic, Borko
Mi, Xinlei
Swaroop, Alok
Winter, Jane
Gordon, Leo I.
Karmali, Reem
Pro, Barbara
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[10] Preliminary Results from a Phase II Study of Chidamide in Combination with CHOP in Previously Untreated Peripheral T-Cell Lymphoma with T Follicular Helper Phenotype (SWIFT study)
Cai, Qingqing
Xia, Yi
Zeng, Dongfeng
Li, Xi
Fang, Xiaojie
Nie, Man
Tian, Xiaopeng
Li, Lirong
Liu, Yingxian
BLOOD, 2024, 144 : 7779 - 7779

← 1 2 3 4 5 →